Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 809

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Systemic Effects of Smoking

Yanbaeva, Dilyara G., Dentener, Mieke A., Creutzberg, Eva C., Wesseling, Geertjan, Wouters, Emiel F.M.·2007·Chest
DOI 10.1378/chest.06-2179
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1378/chest.06-2179

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 80

  1. Crofton, 1989, Smoking as a risk factor for chronic airways disease, Chest, 96(3 suppl), 307S, 10.1378/chest.96.3_Supplement.307S · DOI
  2. Boyle, 1997, Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996, Lung Cancer, 17, 1, 10.1016/S0169-5002(97)00648-X · DOI
  3. van der Vaart, 2004, Acute effects of cigarette smoke on inflammation and oxidative stress: a review, Thorax, 59, 713, 10.1136/thx.2003.012468 · DOI
  4. Pryor, 1993, Oxidants in cigarette smoke radicals, hydrogen peroxides, peroxynitrate, and peroxynitrite, Ann N Y Acad Sci, 28, 12, 10.1111/j.1749-6632.1993.tb39148.x · DOI
  5. Mac Nee, 2005, Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease, Proc Am Thorac Soc, 2, 50, 10.1513/pats.200411-056SF · DOI
  6. van Antwerpen, 1995, Vitamin E, pulmonary functions, and phagocyte-mediated oxidative stress in smokers and nonsmokers, Free Radic Biol Med, 18, 935, 10.1016/0891-5849(94)00225-9 · DOI
  7. Ludwig, 1982, Alterations in leukocyte oxidative metabolism in cigarette smokers, Am Rev Respir Dis, 126, 977
  8. Michaud, 2006, Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities, Atherosclerosis, 187, 423, 10.1016/j.atherosclerosis.2005.10.009 · DOI
  9. Petruzzelli, 1997, Plasma 3-nitrotyrosine in cigarette smokers, Am J Respir Crit Care Med, 156, 1902, 10.1164/ajrccm.156.6.9702075 · DOI
  10. Takajo, 2001, Augmented oxidative stress of platelets in chronic smokers: mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability, J Am Coll Cardiol, 38, 1320, 10.1016/S0735-1097(01)01583-2 · DOI
  11. Pignatelli, 2001, Nitrated and oxidized plasma proteins in smokers and lung cancer patients, Cancer Res, 61, 778
  12. Morrow, 1995, Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: smoking as a cause of oxidative damage, N Engl J Med, 332, 1198, 10.1056/NEJM199505043321804 · DOI
  13. Reilly, 1996, Modulation of oxidant stress in vivo in chronic cigarette smokers, Circulation, 94, 19, 10.1161/01.CIR.94.1.19 · DOI
  14. Helmersson, 2005, Active smoking and a history of smoking are associated with enhanced prostaglandin F(2α), interleukin-6 and F2-isoprostane formation in elderly men, Atherosclerosis, 181, 201, 10.1016/j.atherosclerosis.2004.11.026 · DOI
  15. Gniwotta, 1997, Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions, Arterioscler Thromb Vasc Biol, 17, 3236, 10.1161/01.ATV.17.11.3236 · DOI
  16. Schwedhelm, 2004, Urinary 8-iso-prostaglandin F2α as a risk marker in patients with coronary heart disease: a matched case-control study, Circulation, 109, 843, 10.1161/01.CIR.0000116761.93647.30 · DOI
  17. Rumley, 2004, Plasma lipid peroxides: relationships to cardiovascular risk factors and prevalent cardiovascular disease, QJM, 97, 809, 10.1093/qjmed/hch130 · DOI
  18. Smith, 1993, Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease, Atherosclerosis, 102, 155, 10.1016/0021-9150(93)90157-P · DOI
  19. Orhan, 2005, Erythrocyte antioxidant defense response against cigarette smoking in humans: the glutathione S-transferase vulnerability, J Biochem Mol Toxicol, 19, 226, 10.1002/jbt.20088 · DOI
  20. Ochs-Balcom, 2005, Oxidative stress and pulmonary function in the general population, Am J Epidemiol, 162, 1137, 10.1093/aje/kwi339 · DOI
  21. Rahman, 2000, Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?, Thorax, 55, 189, 10.1136/thorax.55.3.189 · DOI
  22. Wei, 2001, Association of smoking with serum and dietary levels of antioxidants in adults: NHANES III, 1988–1994, Am J Public Health, 91, 258, 10.2105/AJPH.91.2.258 · DOI
  23. Lykkesfeldt, 2000, Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes, Am J Clin Nutr, 71, 530, 10.1093/ajcn/71.2.530 · DOI
  24. Schectman, 1989, The influence of smoking on vitamin C status in adults, Am J Public Health, 79, 158, 10.2105/AJPH.79.2.158 · DOI
  25. Marangon, 1998, Diet, antioxidant status, and smoking habits in French men, Am J Clin Nutr, 67, 231, 10.1093/ajcn/67.2.231 · DOI · Paper page
  26. Fuller, 2000, The effect of vitamin E and vitamin C supplementation on LDL oxidizability and neutrophil respiratory burst in young smokers, J Am Coll Nutr, 19, 361, 10.1080/07315724.2000.10718932 · DOI
  27. Pellegrini, 2004, Vitamin C has no effect on endothelium-dependent vasomotion and acute endogenous fibrinolysis in healthy smokers, J Cardiovasc Pharmacol, 44, 117, 10.1097/00005344-200407000-00016 · DOI
  28. Moriarty, 2003, Oxidation of glutathione and cysteine in human plasma associated with smoking, Free Radic Biol Med, 35, 1582, 10.1016/j.freeradbiomed.2003.09.006 · DOI · Paper page
  29. van Eeden, 2000, The response of human bone marrow to chronic cigarette smoking, Eur Respir J, 15, 915, 10.1034/j.1399-3003.2000.15e18.x · DOI
  30. Wannamethee, 2005, Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease, Eur Heart J, 26, 1765, 10.1093/eurheartj/ehi183 · DOI
  31. Yarnell, 2000, Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study, Arterioscler Thromb Vasc Biol, 20, 271, 10.1161/01.ATV.20.1.271 · DOI
  32. Smith, 2003, Smoking status and differential white cell count in men and women in the EPIC-Norfolk population, Atherosclerosis, 169, 331, 10.1016/S0021-9150(03)00200-4 · DOI
  33. Yarnell, 1987, Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys, J Clin Pathol, 40, 909, 10.1136/jcp.40.8.909 · DOI
  34. Tedder, 1995, The selectins: vascular adhesion molecules, FASEB J, 9, 866, 10.1096/fasebj.9.10.7542213 · DOI
  35. Dash, 1991, High neutrophil myeloperoxidase activity in smokers [letter], Blood, 77, 1619, 10.1182/blood.V77.7.1619a.1619a · DOI
  36. van Eeden, 2005, Systemic response to ambient particulate matter: relevance to chronic obstructive pulmonary disease, Proc Am Thorac Soc, 2, 61, 10.1513/pats.200406-035MS · DOI
  37. Kim, 2002, Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD, Chest, 122, 437, 10.1378/chest.122.2.437 · DOI
  38. Miller, 1982, Reversible alterations in immunoregulatory T cells in smoking: analysis by monoclonal antibodies and flow cytometry, Chest, 82, 526, 10.1378/chest.82.5.526 · DOI
  39. Tanigawa, 1998, Increase in memory (CD4+CD29+ and CD4+CD45RO+) T and naive (CD4+CD45RA+) T-cell subpopulations in smokers, Arch Environ Health, 53, 378, 10.1080/00039899809605724 · DOI
  40. Hughes, 1985, Numerical and functional alterations in circulatory lymphocytes in cigarette smokers, Clin Exp Immunol, 61, 459
  41. Tollerud, 1989, The effects of cigarette smoking on T cell subsets: a population-based survey of healthy Caucasians, Am Rev Respir Dis, 139, 1446, 10.1164/ajrccm/139.6.1446 · DOI
  42. Mili, 1991, The associations of race, cigarette smoking, and smoking cessation to measures of the immune system in middle-aged men, Clin Immunol Immunopathol, 59, 187, 10.1016/0090-1229(91)90017-5 · DOI
  43. Schaberg, 1997, Lymphocyte subsets in peripheral blood and smoking habits, Lung, 175, 387, 10.1007/PL00007585 · DOI
  44. Rohde, 1999, Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men, Am J Cardiol, 84, 1018, 10.1016/S0002-9149(99)00491-9 · DOI
  45. Mendall, 2000, C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men, Eur Heart J, 21, 1584, 10.1053/euhj.1999.1982 · DOI
  46. Bazzano, 2003, Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States, Ann Intern Med, 138, 891, 10.7326/0003-4819-138-11-200306030-00010 · DOI
  47. Bermudez, 2002, Relation between markers of systemic vascular inflammation and smoking in women, Am J Cardiol, 89, 1117, 10.1016/S0002-9149(02)02284-1 · DOI · Paper page
  48. Lowe, 2001, C-reactive protein, fibrin d-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?, Arterioscler Thromb Vasc Biol, 21, 603, 10.1161/01.ATV.21.4.603 · DOI
  49. Kannel, 1987, Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study, Am Heart J, 113, 1006, 10.1016/0002-8703(87)90063-9 · DOI
  50. Gan, 2005, The interactions between cigarette smoking and reduced lung function on systemic inflammation, Chest, 127, 558, 10.1378/chest.127.2.558 · DOI
  51. Engstrom, 2002, Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins, Circulation, 106, 2555, 10.1161/01.CIR.0000037220.00065.0D · DOI
  52. Tappia, 1995, Cigarette smoking influences cytokine production and antioxidant defences, Clin Sci (Lond), 88, 485, 10.1042/cs0880485 · DOI
  53. Lind, 2004, Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins, Arterioscler Thromb Vasc Biol, 24, 577, 10.1161/01.ATV.0000116863.37311.82 · DOI
  54. Danesh, 2000, Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses, BMJ, 321, 199, 10.1136/bmj.321.7255.199 · DOI · Paper page
  55. Ridker, 1998, Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women, Circulation, 98, 731, 10.1161/01.CIR.98.8.731 · DOI
  56. Paul, 2004, C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice, Circulation, 109, 647, 10.1161/01.CIR.0000114526.50618.24 · DOI
  57. Jialal, 2004, C-reactive protein: risk marker or mediator in atherothrombosis?, Hypertension, 44, 6, 10.1161/01.HYP.0000130484.20501.df · DOI
  58. Kamath, 2003, Fibrinogen: biochemistry, epidemiology and determinants, QJM, 96, 711, 10.1093/qjmed/hcg129 · DOI
  59. Ridker, 2000, Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men, Circulation, 101, 1767, 10.1161/01.CIR.101.15.1767 · DOI · Paper page
  60. Cesari, 2003, Inflammatory markers and onset of cardiovascular events: results from the Health ABC study, Circulation, 108, 2317, 10.1161/01.CIR.0000097109.90783.FC · DOI · Paper page
  61. Woodward, 1999, Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease, Br J Haematol, 104, 246, 10.1046/j.1365-2141.1999.01158.x · DOI
  62. Wirtz, 2004, Enhanced glucocorticoid sensitivity of cytokine release from circulating leukocytes stimulated with lipopolysaccharide in healthy male smokers, Brain Behav Immun, 18, 536, 10.1016/j.bbi.2004.01.002 · DOI
  63. Gander, 2004, Effect of the G-308A polymorphism of the tumor necrosis factor (TNF)-α gene promoter site on plasma levels of TNF-α and C-reactive protein in smokers: a cross-sectional study, BMC Cardiovasc Disord, 4, 17, 10.1186/1471-2261-4-17 · DOI
  64. Lowe, 1997, Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study, Br J Haematol, 96, 168, 10.1046/j.1365-2141.1997.8532481.x · DOI
  65. Koenig, 2000, Association between plasma viscosity and all-cause mortality: results from the MONICA-Augsburg Cohort Study 1984–92, Br J Haematol, 109, 453, 10.1046/j.1365-2141.2000.02026.x · DOI
  66. Lowe, 2004, Tissue plasminogen activator antigen and coronary heart disease: prospective study and meta-analysis, Eur Heart J, 25, 252, 10.1016/j.ehj.2003.11.004 · DOI
  67. Node, 1997, Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults, Am J Cardiol, 79, 1538, 10.1016/S0002-9149(97)00189-6 · DOI
  68. Yamaguchi, 2005, Facilitated nitration and oxidation of LDL in cigarette smokers, Eur J Clin Invest, 35, 186, 10.1111/j.1365-2362.2005.01472.x · DOI
  69. Stocker, 2004, Role of oxidative modifications in atherosclerosis, Physiol Rev, 84, 1381, 10.1152/physrev.00047.2003 · DOI
  70. Harding, 2004, Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers, Circulation, 109, 1926, 10.1161/01.CIR.0000127128.52679.E4 · DOI
  71. Schonbeck, 2002, Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells, Circulation, 106, 2888, 10.1161/01.CIR.0000043029.52803.7B · DOI
  72. Bergmann, 1998, Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1, Respir Physiol, 114, 269, 10.1016/S0034-5687(98)00098-X · DOI
  73. Scott, 2000, Dramatic decline in circulating intercellular adhesion molecule-1 concentration on quitting tobacco smoking, Blood Cells Mol Dis, 26, 255, 10.1006/bcmd.2000.0304 · DOI
  74. Behrendt, 2002, Endothelial function: from vascular biology to clinical applications, Am J Cardiol, 90, 40L, 10.1016/S0002-9149(02)02963-6 · DOI
  75. Newby, 1999, Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction, Circulation, 99, 1411, 10.1161/01.CIR.99.11.1411 · DOI
  76. Eliasson, 1995, Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin: the Northern Sweden MONICA Study, Atherosclerosis, 113, 41, 10.1016/0021-9150(94)05425-I · DOI
  77. Yarnell, 2001, Lifestyle factors and coagulation activation markers: the Caerphilly Study, Blood Coagul Fibrinol, 12, 721, 10.1097/00001721-200112000-00015 · DOI
  78. Lowe, 1999, Use of fibrinogen and fibrin d-dimer in prediction of arterial thrombotic events, Thromb Haemost, 82, 667, 10.1055/s-0037-1615895 · DOI
  79. Cambien, 2005, Atherosclerosis: from genetic polymorphisms to system genetics, Cardiovasc Toxicol, 5, 143, 10.1385/CT:5:2:143 · DOI
  80. Collins, 1997, Variations on a theme: cataloging human DNA sequence variation, Science, 278, 1580, 10.1126/science.278.5343.1580 · DOI · Paper page

Cited by

See all 809

Metadata

Authors
Yanbaeva, D. G., Dentener, M. A., Creutzberg, E. C., Wesseling, G., & Wouters, E. F. M.
Venue
Chest
Publisher
Elsevier BV
Published
2007-05
Volume
131
Issue
5
Pages
1557-1566
ISSN
0012-3692
DOI
10.1378/chest.06-2179
Cited by
809
References
6
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.